FindTrial
Sign In

The Meaning of Intravenous Iron Supplementation In Acute Mountain Sickness: A Randomized, Double-Blinded, Placebo-Controlled Trail

The Meaning of Intravenous Iron Supplementation In Acute Mountain Sickness: A Randomized, Double-Blinded, Placebo-Controlled Trail

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR-TRC-13003590
Enrollment
Unknown
Registered
2013-06-23
Start date
2013-07-30
Completion date
Unknown
Last updated
2017-04-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

acute mountain sickness

Interventions

intercention group:intravenous iron 2oomg
Control:Placebo 0.9% NS

Sponsors

Department of Emergency of the General Hospital of PLA
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 65 Years

Inclusion criteria

Inclusion criteria: 1,healthy subjects ready to travel from Beijing to Tibet by air;2,subjects knowing the aim of the study and giving informed consent.

Exclusion criteria

Exclusion criteria: Subject not finishing the procedure; subject with coronary heart disease and uncontrolled hypertention and other severe diseases; And subject wite anemia especially iron deficiency anemia.

Design outcomes

Primary

MeasureTime frame
serum iron;Lake Louise Score;—

Countries

China

Contacts

Public ContactYe Ping
yeping301@sina.com+86 13501100755

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026